Chiropractors in Hamilton, MT Accepting Medicare

23 Chiropractors found. Showing 21 - 23

Dr. Jessie L Wheeler, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 809 S 1st St, Hamilton, MT 59840 Phone: 406-961-9022

Dr. Jack Barnings, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1019 W Main St, Hamilton, MT 59840 Phone: 406-375-5332    Fax: 406-375-5350

Dr. James J Kostecki, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 1201 W Main St, Hamilton, MT 59840 Phone: 406-363-3333

News Archive

Epilepsy deaths should be considered a public health priority, say doctors

Epilepsy is not a public health priority, yet it takes more lives than sudden infant death syndrome (SIDS) or fires, according to an article reviewing the topic. Doctors say epilepsy deaths should be a focus of research and education to understand and prevent those deaths, according to the "Views and Reviews" article published in the December 16, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.

Pulmatrix completes previously announced merger and closes $10 million in private placement

Pulmatrix, Inc., previously known as Ruthigen, Inc., today announced the completion of its previously announced merger, effective June 15, 2015, and the closing of a private placement generating aggregate gross proceeds of $10.0 million. Participants in the private placement included pre-merger investors in Pulmatrix such as funds affiliated with 5AM Ventures, ARCH Venture Partners and Polaris Partners, as well as funds affiliated with Altitude Life Science Ventures.

Distinct clusters of genetic markers linked to treatment responses for smoking cessation

Scientists have identified distinct clusters of genetic markers associated with the likelihood of success or failure of two smoking cessation treatments, nicotine replacement therapy (NRT) and the medication bupropion (Zyban). This study, supported by the National Institute on Drug Abuse (NIDA) and the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), was published in the June issue of the journal Archives of General Psychiatry.

NCI awards Altor Bioscience a $3 MM grant to develop its targeted cancer therapeutic ALT-801

Altor BioScience Corporation announced today that it has been awarded a Small Business Innovation Research (SBIR) Phase II Bridge Grant by the National Cancer Institute (NCI). The award of $3 MM over three years will help Altor further its clinical development of ALT-801, a novel tumor-targeted immunotherapeutic designed to improve the efficacy and safety of the FDA-approved anticancer cytokine, interleukin-2 (IL-2).

Read more Medical News

› Verified 3 days ago

• 1
• 2(current)